VINC

Vincerx Pharma, Inc. Common Stock

Delisted

VINC was delisted on the 22nd of April, 2025.

1 hedge funds and large institutions have $2 invested in Vincerx Pharma, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-13
Holders Change %
-92.86%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
BTC
1
Bank & Trust Company
Illinois
$2 +$2 +50 New
SRC
2
Sage Rhino Capital
California
-$45.1K -85,170 Closed
Citadel Advisors
3
Citadel Advisors
Florida
-$22.6K -42,777 Closed
Goldman Sachs
4
Goldman Sachs
New York
-$16.7K -31,567 Closed
Geode Capital Management
5
Geode Capital Management
Massachusetts
-$10.2K -19,285 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
-$7.57K -14,317 Closed
TSS
7
Two Sigma Securities
New York
-$5.85K -11,053 Closed
Millennium Management
8
Millennium Management
New York
-$5.72K -10,798 Closed
TRCT
9
Tower Research Capital (TRC)
New York
-$1.59K -2,997 Closed
BlackRock
10
BlackRock
New York
-$1.25K -2,352 Closed
UBS Group
11
UBS Group
Switzerland
-$75 -142 Closed
Morgan Stanley
12
Morgan Stanley
New York
-$54 -102 Closed
SS
13
SBI Securities
Japan
-$26 -50 Closed
Bank of America
14
Bank of America
North Carolina
-$8 -15 Closed
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
-$1 -1 Closed